Concepedia

Kathryn Monopoli

KM

Statistics

Publications

7

Citations

292

H-Index

7

Active since

2018

Affiliations

University of Massachusetts Chan Medical School(Current)

Worcester Polytechnic Institute

Leo Pharma (Denmark)

Kathryn Monopoli is an author at University of Massachusetts Chan Medical School specializing in rna interference, life sciences, and small interfering rna biology.

ORCID

Publications per year

2018–2025

7

Publications

7

Functional features defining the efficacy of cholesterol-conjugated, self-deliverable, chemically modified siRNAs

Taisia Shmushkovich, Kathryn Monopoli, Diana Homsy et al. · Nucleic Acids Research · 2018 · 76 citations · Full text

, , +15

Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntington’s disease

Daniel O’Reilly, Jillian Belgrad, Chantal Ferguson et al. · Molecular Therapy · 2023 · 54 citations · Full text

, , +17

Rational design of a JAK1-selective siRNA inhibitor for the modulation of autoimmunity in the skin

Qi Tang, Hassan H. Fakih, Mohammad Zain UI Abideen et al. · Nature Communications · 2023 · 49 citations · Full text

, , +17

Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection

Vignesh Hariharan, Minwook Shin, Ching‐Wen Chang et al. · Proceedings of the National Academy of Sciences · 2023 · 48 citations · Full text

, , +17

RNAi-based modulation of IFN-γ signaling in skin

Qi Tang, Jacquelyn Sousa, Dimas Echeverria et al. · Molecular Therapy · 2022 · 33 citations · Full text

, , +17

1–5 of 7